Top Story

Boston keratoprosthesis complication rate high in children

September 23, 2017

Boston type 1 keratoprosthesis implantation in children was associated with a high complication rate, device failure and poor visual outcome in a retrospective case series generated at three tertiary referral centers in Canada.

The study included 11 eyes of 11 patients aged 16 years or younger who underwent KPro implantation between January 2010 and November 2014. Five eyes were operated on after prior donor graft failure, while in the other six KPro implantations were performed as a primary procedure. The primary diagnoses were Peters anomaly type II, aniridia and sclerocornea. All eyes had a history of glaucoma. Preoperative visual acuity ranged from 20/600 to light perception.

In the Journals

Treat-and-extend comparable to monthly injections in AMD

September 22, 2017
A multicenter 12-month phase 3b study showed that treat-and-extend administration of ranibizumab is “statistically noninferior and clinically comparable”…

European Commission approves Actemra/RoActemra for giant cell arteritis

September 22, 2017
Actemra/RoActemra has been approved by the European Commission for the treatment of giant cell arteritis, according to a Roche press release. The anti-IL-6 receptor…

Gurman says, ‘Our voice is their voice’ in explaining the importance of physician advocacy

September 22, 2017
At a time when the state of health care is in flux, it is critical that physicians engage in the national debate by telling their stories and those of their patients to…

AAO recommends shingles vaccine at 50 years

September 22, 2017
A shingles vaccine is now recommended for individuals aged 50 years and older, 10 years younger than a previous recommendation, according to the American Academy of…
More Headlines »
Original Article

Progression of High Anisometropia in Children

Journal of Pediatric Ophthalmology and Strabismus, September/October 2017, Volume 54 Issue 5
To investigate the onset and rate of progression of high anisometropia in myopic children younger than 13 years. A…
More »

Glaucoma 2017: Controlling IOP and Promoting Adherence through Novel Therapeutics

This activity is supported by an educational grant from Aerie Pharmaceuticals, Inc.

Glaucoma is currently the second leading cause of blindness throughout the world. The goal of glaucoma treatment is to…
More »
Resource Centers
American Society of Retina Specialists Meeting

American Society of Retina Specialists Meeting

Meeting News

VIDEO: WIO brings women academics, private practice ophthalmologists together

August 16, 2017
More »